Quarterly Snapshot: Quick and Current Ratios for Astria Therapeutics Inc (ATXS)

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

The closing price of Astria Therapeutics Inc (NASDAQ: ATXS) was $9.55 for the day, up 2.14% from the previous closing price of $9.35. In other words, the price has increased by $2.14 from its previous closing price. On the day, 0.54 million shares were traded. ATXS stock price reached its highest trading level at $9.86 during the session, while it also had its lowest trading level at $9.36.

Ratios:

Our analysis of ATXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.73 and its Current Ratio is at 21.73. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on March 28, 2023, initiated with a Outperform rating and assigned the stock a target price of $18.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 01 ’24 when Morabito Christopher sold 10,000 shares for $13.59 per share. The transaction valued at 135,939 led to the insider holds 0 shares of the business.

PERCEPTIVE ADVISORS LLC bought 2,481,350 shares of ATXS for $29,999,522 on Feb 01 ’24. The Director now owns 4,873,721 shares after completing the transaction at $12.09 per share. On Jan 29 ’24, another insider, Morabito Christopher, who serves as the Chief Medical Officer of the company, sold 9,200 shares for $11.15 each. As a result, the insider received 102,552 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 524420128 and an Enterprise Value of 373447232.

Stock Price History:

Over the past 52 weeks, ATXS has reached a high of $16.90, while it has fallen to a 52-week low of $4.26. The 50-Day Moving Average of the stock is -24.52%, while the 200-Day Moving Average is calculated to be 6.02%.

Shares Statistics:

ATXS traded an average of 1.04M shares per day over the past three months and 1134170 shares per day over the past ten days. A total of 54.91M shares are outstanding, with a floating share count of 44.72M. Insiders hold about 18.56% of the company’s shares, while institutions hold 67.37% stake in the company. Shares short for ATXS as of 1713139200 were 5046064 with a Short Ratio of 4.85, compared to 1710460800 on 2012943. Therefore, it implies a Short% of Shares Outstanding of 5046064 and a Short% of Float of 9.55.

Most Popular

[the_ad id="945"]